REXN Chart
- 52-Week Range: $1.26 - $5.77
- Market Capitalization: $9.36M
- Short Percentage: 0%
- Target Price: $3.00
- Shares Outstanding: 4.48M
- Next Earnings: Nov 30
Catalysts
CategoryCatalyst
No upcoming catalysts found
News and Press Releases
- KalVista Pharmaceuticals Announces Non-Proprietary Name Selection for KVD900Business Wire | May 17th
- Vertex Announces $50 Million Commitment to Health Equity With Three Initial GrantsBusiness Wire | May 17th
- Henry Schein Appoints Dirk Benson Chief Commercial Officer, North America Distribution GroupBusiness Wire | May 17th
- 4D pharma conference poster underlines safety and potential efficacy of asthma drug candidateProactive Investors | May 17th
- FDA and Abbott Nutrition reach deal to restart production of baby formula amid nationwide shortageBusiness Insider | May 16th
- Albireo Pharma, Inc. (ALBO) CEO Ron Cooper on Q1 2022 Results - Earnings Call TranscriptSeeking Alpha | May 16th
We searched over 50 sources and couldn't find any news or press releases related to Rexahn Pharmaceuticals.
Here are some articles we think you might like.
Company Info
Website: http://www.rexahn.com
Address: 15245 Shady Grove Road, Rockville, MD, United States, 20850
Sector: Healthcare
Industry: Biotechnology
Full time employees: 5
Address: 15245 Shady Grove Road, Rockville, MD, United States, 20850
Sector: Healthcare
Industry: Biotechnology
Full time employees: 5
$REXN love cooking these little bears on here
$REXN Pamp it higher...
$REXN down hard at open
$REXN Free money indeed??
$REXN Looks like a solid reversal - retesting support right now
definitely thinking about swinging this
$REXN How can this stock move so little? Damn
$REXN I already know
tomorrow the bulls going to say "next week" just like every week.
$REXN let's gooooooo
$REXN Getting ready for market open.
$REXN omg lol